RDHLRedHill Biopharma Ltd.
- Market cap
- $3.76M
- as of 2026-10-23
- Latest close
- $0.42
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-04-22
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Raday GileadChief Operating Officer | Oct 1 | Oct 6 | S | 14,310,000 | $0.00 | Sale −$1,431 | 176,910,000 | No | Form 4 |
| Raday GileadChief Operating Officer | Oct 1 | Oct 6 | M · derivative | 27,560,000 | $0.00 | $0 | 131,690,000 | No | Form 4 |
| Raday GileadChief Operating Officer | Jul 10 | Jul 13 | S | 14,130,000 | $0.00 | Sale −$0 | 218,780,000 | No | Form 4 |
| Raday GileadChief Operating Officer | Jul 10 | Jul 13 | M · derivative | 28,150,000 | $0.00 | $0 | 104,130,000 | No | Form 4 |
| Raday GileadChief Operating Officer | Apr 6 | Apr 22 | S | 15,740,000 | $0.00 | Sale −$0 | 261,060,000 | No | Form 4 |
| Raday GileadChief Operating Officer | Apr 6 | Apr 22 | M · derivative | 30,780,000 | $0.00 | $0 | 76,150,000 | No | Form 4 |